Detalhe da pesquisa
1.
A CD138-independent strategy to detect minimal residual disease and circulating tumour cells in multiple myeloma.
Br J Haematol
; 173(1): 70-81, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26729247
2.
Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia.
Blood
; 121(8): 1296-303, 2013 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23287861
3.
PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance.
Br J Haematol
; 165(1): 89-101, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24405121
4.
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features.
Blood
; 119(24): 5782-94, 2012 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22394600
5.
P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment.
Blood
; 119(6): 1468-78, 2012 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22096244
6.
LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas.
Blood
; 120(8): 1678-86, 2012 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22797699
7.
PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma.
Haematologica
; 104(7): e310-e313, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30655367
8.
Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib.
Am J Hematol
; 89(11): 1030-6, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25060991
9.
Defining the role of TORC1/2 in multiple myeloma.
Blood
; 118(26): 6860-70, 2011 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22045983
10.
microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia.
Blood
; 116(9): 1506-14, 2010 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20519629
11.
Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenstrom macroglobulinemia.
Blood
; 115(20): 4051-60, 2010 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20110419
12.
Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia.
Blood
; 115(3): 559-69, 2010 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19965685
13.
microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia.
Blood
; 113(18): 4391-402, 2009 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-19074725
14.
RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma.
Blood
; 114(3): 619-29, 2009 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19443661
15.
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma.
Blood
; 113(26): 6669-80, 2009 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19401561
16.
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.
Blood
; 113(18): 4341-51, 2009 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-19139079
17.
A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma.
Sci Rep
; 11(1): 19343, 2021 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34588522
18.
Dual targeting of the proteasome regulates survival and homing in Waldenstrom macroglobulinemia.
Blood
; 111(9): 4752-63, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18316628
19.
SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia.
Blood
; 112(1): 150-8, 2008 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18448868
20.
Targeting NF-kappaB in Waldenstrom macroglobulinemia.
Blood
; 111(10): 5068-77, 2008 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18334673